[The clinico-biochemical activity and tolerance of the hypolipidemic preparation lipanthyl].
There were 56 patients with hyperlipoproteinemias, treated with lipantil in a dose of 300-600 mg/day. After 8 weeks of the treatment the blood triglyceride content declined by 65.4%, the blood content of total cholesterol 24.1%, that of low density lipoprotein cholesterol 21.1%, of very low density lipoprotein cholesterol 34.1%; the content of high density lipoprotein cholesterol rose by 28.0%. The drug also exerted a uricosuric action. The rate of side effects was 3.6%.
Ol'binskaia
L I
LI
Vartanova
O A
OA
Aleksandrovskaia
T N
TN
Shaldaeva
V V
VV
D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D011345:Fenofibrate / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy; D006953:Hyperlipoproteinemia Type IV / Q000097:blood / Q000188:drug therapy; D006954:Hyperlipoproteinemia Type V / Q000097:blood / Q000188:drug therapy; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D008055:Lipids; D008074:Lipoproteins; D011345:Fenofibrate
Kliniko-biokhimicheskaia aktivnost' i perenosimost' gipolipidemicheskogo preparata lipantil.